ZS Recognized as Leader in IDC MarketScape for Life Sciences R&D
ZS earns recognition for its capabilities in real-world data and evidence.
ZS, a global management consulting and technology firm, has been acknowledged as a Leader in the IDC MarketScape for its contributions to real-world data (RWD) and real-world evidence (RWE) within the life sciences sector. This recognition is part of the 2026 Vendor Assessment, which evaluates organizations on their strategies and capabilities related to data platforms, technology solutions, and consulting services.
The IDC MarketScape assessment highlights ZS's integrated Medical & Evidence practice, which aims to enhance decision-making by connecting evidence generation with downstream dissemination. ZS has developed various platforms, including ZAIDYN Medical, which offers multiple intelligence services for medical science liaisons and patient outcome analysis.
One notable feature of ZS's offerings is the AI-enabled Patient Radar platform, which assists in identifying rare-disease patients and physicians. The firm reported that it facilitated the accurate diagnosis of 26 new patients within a year for a rare disease organization, showing its impact on patient care.
In Europe, ZS's Data Nexus serves as a regulatory-grade RWD access platform, recognized as the first RWE solution to achieve Europrivacy certification. The firm has also noted a high client satisfaction rate, with a 90% Net Promoter Score (NPS) and a 97% retention rate for its RWD/RWE services.
ZS’s digital Integrated Evidence Planning (IEP) capability has significantly accelerated the development of evidence plans, reducing the time needed to create over 30 IEPs to just 10 weeks, with a 75% acceptance rate for protocol recommendations. This speed is crucial as life sciences organizations increasingly face the need for timely evidence to support regulatory and commercial decisions.
Overall, ZS's recognition as a Leader in the IDC MarketScape highlights its commitment to transforming real-world data into actionable insights, which is essential for enhancing decision-making across the product life cycle in the life sciences industry. This announcement was distributed via PR Newswire.
This is an independent summary of a press release originally distributed via PR Newswire. GAX Online was not paid for this coverage.
Have news to announce?
Get your launch, funding round, or partnership covered on GAX Online, in front of tech buyers and the AI answer engines that cite us.
Submit your press release →